From: Is age a risk factor for liver disease and metabolic alterations in ataxia Telangiectasia patients?
Variable |  | A-T Group (n = 18) | Controls (n = 17) | p Value |
---|---|---|---|---|
Total cholesterol | mg/dL | 177.4 ± 33.3 | 170.0 ± 25.4 | 0.448a |
LDL-c | mg/dL | 115.4 ± 32.3 | 107.6 ± 22.3 | 0.412a |
HDL-c | mg/dL | 43.5 ± 10.8 | 45.2 ± 8.1 | 0.596a |
Triglycerides | mg/dL | 94.1 ± 47.2 | 91.7 ± 45.8 | 0.880a |
Non-HDL-cholesterol | mg/dL | 134.2 ± 35.7 | 124.8 ± 25.6 | 0.377a |
Total cholesterol/HDL-c | mg/dL | 4.3 ± 1.4 | 3.9 ± 0.9 | 0.265a |
LDL/HDL | mg/dL | 2.8 ± 1.1 | 2.5 ± 0.8 | 0.272a |
Apo A-I | mg/mL | 130.8 ± 27.2 | 138.8 ± 19.8 | 0.330a |
Apo B | mg/mL | 274.1 ± 184.4 | 167.0 ± 46.0 | 0.027 a |
Apo B/Apo AI | mg/mL | 2.1 ± 1.4 | 1.2 ± 0.3 | 0.018 a |
LDL/ApoB | mg/mL | 0.56 ± 0.42 | 0.67 ± 0.15 | 0.327a |
Lp(a) | pg/mL | 182.8 (31.2;585.8) | 31.2 (31.2;334.9) | 0.001 b |
LDLox | pg/mL | 2610.0 ± 985.0 | 2338.4 ± 982.6 | 0.533a |
sdLDL-c | mmol/L | 3.3 ± 0.9 | 3.2 ± 0.9 | 0.641a |